General Information
Version
1.0
Revision date
2025-12-23
Product name
Nasier Cartaceo DT-03
1.2.1 Relevant identified uses
Professional use
Emergency telephone
+39 0444-1343163
Icons in SDS
Company Information
company name
Brenta s.r.l
e-mail address of the competent person responsible for the Safety Data Sheet
nasier@brenta.net
Section 2
SECTION 2: Hazards identification
EC/648/2004 Classification of the substance or mixture Classification according to GB CLP (SI 2019:720 as amended) Not classified
Adverse physicochemical, human health and environmental effects
Under normal conditions of use, the mixture does not cause adverse effects to humans and to the environment. Any additional information concerning the risks for health and/or the environment are given in sections 11 and 12 of this sheet. Contains Amylase, α-, may produce an allergic reaction in already sensitized persons
2.2 Label elements
Labelling according to GB CLP (SI 2019:720 as amended)
Supplemental label elements
(GHS UK) EUH208 - Contains Amylase, α-(9001-19-8). May produce an allergic reaction. EUH210 - Safety data sheet available on request.
Additional information
(GHS UK)
Contains
(Reg. 648/2004*) zeolites less than 5%, enzymes *Regulation (EC) 648/2004 as amended by the Detergents EU Exit Statutory Instruments (SIs)
Results of PBT and vPvB assessment
Component Substance(s) not meeting the PBT criteria of UK Amylase, α- (9001-19-8), Zeolite silica-rich (1318-02-1) REACH regulation, in accordance with Annex XIII Substance(s) not meeting the vPvB criteria of UK Amylase, α- (9001-19-8), Zeolite silica-rich (1318-02-1) REACH regulation, in accordance with Annex XIII Results of Endocrine Disruptor assessment Component Substance(s) not considered as endocrine disrupting. Amylase, α-(9001-19-8), Zeolite silica-rich (1318-02-1) They are not included in the list established in accordance with Article 59(1) of UK REACH for having endocrine disrupting properties, nor identified as having endocrine disrupting properties in accordance with the criteria set out in GB BPR and GB PPP
Further information
Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII. The mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Classification according to GB CLP (SI 2019:720 as amended) Not classified Adverse physicochemical, human health and environmental effects Under normal conditions of use, the mixture does not cause adverse effects to humans and to the environment. Any additional information concerning the risks for health and/or the environment are given in sections 11 and 12 of this sheet. Contains Amylase, α-, may produce an allergic reaction in already sensitized persons.